Global Combined Angiography Market Size By Type (Discovery IGS System, MIYABI Angio-CT), By Application (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Combined Angiography Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.8 billion by 2031, growing at a CAGR of 8.2% during the forecast period from 2023 to 2031. This growth is primarily driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and advancements in imaging technologies. Combined angiography systems, which integrate different imaging modalities such as CT, MRI, and fluoroscopy, are revolutionizing diagnostics and interventional procedures by offering higher precision and real-time visualization.

Drivers:

Rising Incidence of Cardiovascular and Neurological Disorders:

The global burden of cardiovascular and cerebrovascular conditions has significantly increased, creating demand for advanced diagnostic tools like combined angiography systems. These systems aid in early detection and planning of complex interventional procedures.

Technological Advancements in Imaging:

Rapid innovations in imaging technologies, including real-time 3D imaging and fusion imaging techniques, are enhancing the capabilities of angiography systems. These advancements reduce procedure time and improve diagnostic accuracy.

Growing Preference for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly favoring minimally invasive interventions due to reduced recovery time, lower risk of infection, and better outcomes. Combined angiography systems support image-guided procedures with enhanced precision.

Restraints:

High Equipment and Installation Costs:

The capital investment required for combined angiography systems is substantial, especially for systems integrating multiple imaging modalities. This can limit adoption in small and mid-sized hospitals, particularly in developing regions.

Regulatory and Reimbursement Challenges:

Complex regulatory pathways and inadequate reimbursement structures for advanced imaging techniques in several countries can restrict market penetration and delay product approvals.

Opportunity:

Expansion of Hybrid Operating Rooms:

The growing trend of hybrid operating rooms, where imaging and surgical facilities are integrated, offers significant growth potential. Combined angiography systems are essential components in these settings for intraoperative guidance and verification.

Increasing Investments in Healthcare Infrastructure:

Emerging economies are investing heavily in improving healthcare infrastructure, creating opportunities for the installation of advanced diagnostic systems. Public-private partnerships and health-tech funding are accelerating this trend.

Market by System Type Insights:

By system type, the Biplane Angiography Systems segment held the largest market share in 2023. Biplane systems provide simultaneous two-plane imaging, enabling better visualization and reduced contrast usage, especially critical in neurovascular and pediatric interventions. On the other hand, Hybrid Angiography Systems are expected to register the fastest growth due to their versatility in accommodating both diagnostics and interventions in a single setup.

Market by End-use Insights:

In terms of end use, Hospitals dominated the market in 2023, accounting for over 60% of the total share. The wide deployment of angiography units in hospital settings is driven by the increasing need for complex cardiovascular and neurovascular interventions. Meanwhile, Specialty Clinics and Cardiac Centers are projected to witness rapid adoption during the forecast period as they expand imaging capabilities for outpatient procedures.

Market by Regional Insights:

Geographically, North America led the global combined angiography market in 2023, driven by strong healthcare infrastructure, high healthcare spending, and rapid adoption of advanced medical technologies. However, Asia-Pacific is anticipated to record the highest CAGR through 2031 due to the rising prevalence of chronic diseases, increasing medical tourism, and ongoing investment in public health infrastructure in countries like China and India.

Competitive Scenario:

Leading companies in the combined angiography market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corporation, Shimadzu Corporation, and Medtronic plc. These players are focusing on technological innovation, AI integration, and strategic partnerships to maintain competitive advantage. Recent developments include:

2023: Siemens Healthineers launched its next-gen ARTIS icono biplane system with enhanced neurovascular capabilities.

2024: GE Healthcare partnered with major hospitals in Europe to deploy AI-driven angiography suites.

2025: Philips Healthcare introduced its latest hybrid OR-compatible angiography system integrated with real-time 3D imaging and robotic arm technology.

Scope of Work – Global Combined Angiography Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 5.8 billion

CAGR (2023-2031) 8.2%

Market Segments By System Type (Biplane, Hybrid, Single-plane), By End-use, By Region

Growth Drivers Technological advancements, rising CVD prevalence, minimally invasive trends

Opportunities Hybrid operating rooms, healthcare investments in emerging markets

Key Market Developments:

March 2023: Canon Medical Systems launched an AI-powered hybrid angiography system aimed at reducing procedure time and contrast media usage.

August 2024: Shimadzu Corporation announced the global launch of its ceiling-mounted angiography suite with enhanced neuroimaging capabilities.

January 2025: Medtronic expanded its interventional imaging portfolio through the acquisition of a real-time imaging start-up specializing in catheter guidance systems.

FAQs:

1) What is the current market size of the Global Combined Angiography Market?

The Global Combined Angiography Market was valued at USD 3.1 billion in 2023.

2) What is the major growth driver of the Global Combined Angiography Market?

The primary driver is the increasing prevalence of cardiovascular and neurological disorders coupled with technological advancements in imaging.

3) Which is the largest region during the forecast period in the Global Combined Angiography Market?

North America holds the largest market share, while Asia-Pacific is the fastest growing.

4) Which segment accounted for the largest market share in Global Combined Angiography Market?

The Biplane Angiography Systems segment led the market in 2023.

5) Who are the key market players in the Global Combined Angiography Market?

Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Shimadzu Corporation, and Medtronic plc.